Discover a non-invasive diagnostic model for primary Sjögren’s disease using salivary biomarkers, serum autoantibodies, and ...

The Phase 1 GALLOP study evaluating the investigational CAR-T therapy, CB-010, for treatment of lupus nephritis has launched.

Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting ...